Greg Cantin is a Senior Principal Scientist in Biosimilars Process Development at Amgen, where they focus on advancing biopharmaceuticals. They previously held roles as a Group Leader and Scientist at Pfenex Inc, a Research Scientist at Shire, and a Senior Scientist at Five Prime Therapeutics. Greg has also contributed to mass spectrometry and proteomics during their post-doctoral work at The Scripps Research Institute. They earned a Ph.D. in Molecular Biology from UCLA and are currently pursuing a Bachelor of Science in Biochemistry at UC San Diego.
This person is not in the org chart
This person is not in any teams
This person is not in any offices